Ecovyst Stock Earnings Reports

Ecovyst reported a strong start to 2026 with Q1 sales up ~50% year-over-year and adjusted EBITDA of $40 million (up 87% vs. Q1 2025). Growth was driven by higher volumes and favorable pricing in Regeneration Services (benefitting from high U.S. refinery utilization and less customer downtime) and higher virgin sulfuric acid volumes (including contribution from the acquired Wagaman assets and increased mining demand). The company repurchased ~$36 million of stock in the quarter, finished Q1 with net debt of $234 million (1.2x leverage) and liquidity of $237 million. Management announced an agreement to acquire Calabrian (sulfur dioxide and sulfur-derivatives business) for $190 million (roughly 8x TTM adjusted EBITDA of ~$24 million), expected to close by end of Q2, funded with cash and new debt (pro forma leverage at close ~2x) and expected to deliver both cost and revenue synergies. Company guidance was updated (excluding Calabrian): full-year 2026 sales now expected $890M–$970M (up due to ~$30M incremental sulfur cost pass-through), adjusted EBITDA tightened to $180M–$195M, and adjusted free cash flow tightened to $40M–$55M. Management reiterated that higher sulfur costs are largely passed through to customers (neutral to EBITDA dollar results but compressing margin percentages) and expects favorable demand trends to continue driven by refinery utilization and mining projects.